Drug combination highlights potential new depression treatment
Scientists at our University have identified that a combination of two existing licensed drugs could be used as a potential new treatment for depression.
Jun 15, 2015
0
114
Scientists at our University have identified that a combination of two existing licensed drugs could be used as a potential new treatment for depression.
Jun 15, 2015
0
114
A Norwegian drug firm on Tuesday announced an advance in its quest for an HIV cure with a drug combination which seeks to force the virus out of its hiding place and kill it.
Dec 22, 2015
0
76
A combination of two drugs—one of them an immunotherapy agent—could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting ...
Feb 17, 2019
0
62
Research from Kent's School of Biosciences and the Goethe-University Frankfurt am Main, has found a drug combination that may improve treatment for diseases caused by herpes simplex viruses such as cold sore, genital herpes, ...
Mar 13, 2020
0
28
UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer ...
Oct 10, 2017
0
813
(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.
Jul 19, 2016
0
20
More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment ...
Nov 15, 2021
0
10
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by ...
Nov 25, 2021
0
151
A drug combination targeting multiple mutant versions of cancer's "death star" protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.
Jun 6, 2022
0
541
A protein called GRP78 could be a universal therapeutic target for treating human diseases like brain cancer, Ebola, Influenza, Hepatitis and superbug bacteria such as MRSE and MRSA, according to a Virginia Commonwealth University-led ...
Dec 29, 2014
1
1